+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Impact of adding prophylactic probiotics to a bundle of standard preventative measures for Clostridium difficile infections: enhanced and sustained decrease in the incidence and severity of infection at a community hospital



Impact of adding prophylactic probiotics to a bundle of standard preventative measures for Clostridium difficile infections: enhanced and sustained decrease in the incidence and severity of infection at a community hospital



Current Medical Research and Opinion 29(10): 1341-1347



In 2003, hospitals in Quebec, Canada experienced an increase of NAP1/027 Clostridium difficile infections following antibiotic administration (CDIAA). At Pierre-Le Gardeur Hospital (PLGH), the incidence increased from 10 to over 25 cases per 1000 patient admissions. We report a quasi-experimental, prospective cohort study evaluating the effect on CDIAA of a probiotic added to existing C. difficile infection (CDI) standard preventative measures (SPM) in 31,832 hospitalized patients receiving antibiotics. Phase I (1580) measured the impact of SPM alone. In Phase II, 50 to 60 × 10(9) cfu daily dose of oral Lactobacillus acidophilus CL1285 and L. casei LBC80R probiotic formula (Bio-K+) was administered to all patients receiving antibiotics. Phase III included the same intervention after a move to a new hospital facility. Phases II and III included 4968 patients. During Phase IV, 25,284 patients were submitted to the same regimen but outcome data were compared to those of similar hospitals in Quebec. At the end of Phase III, CDIAA had decreased from more than 18 cases per 1000 patient admissions in Phase I to less than 5 cases. Reductions of CDI cases (73%) (p < 0.001) and severe CDI cases (76.4%) (p < 0.001) were observed. CDI recurrence rate was reduced by 39% (p < 0.001). During the following 6 years, the CDI rate averaged 2.71 cases per 10,000 patient-days at PLGH compared to 8.50 cases per 10,000 patient-days in equivalent hospitals located in Quebec. This study is not a randomized clinical trial; it is an open prospective study and should be treated as such. Also, following Phase II, PLGH moved into a new facility and this could have contributed to lower CDI. Specific probiotic product added to SPM and antibiotic stewardship activities resulted in a further reduction in CDI rates and was shown to be safe.

(PDF emailed within 0-6 h: $19.90)

Accession: 053711552

Download citation: RISBibTeXText

PMID: 23931498

DOI: 10.1185/03007995.2013.833501


Related references

Risk Factors for Recurrent Clostridium difficile Infections and Strategies to Decrease Readmissions in a Community Hospital. Hospital Pharmacy 50(11): 1003-1010, 2016

Proposed checklist of hospital interventions to decrease the incidence of healthcare-associated Clostridium difficile infection. Infection Control and Hospital Epidemiology 30(11): 1062-1069, 2010

Impact of a prevention bundle on Clostridium difficile infection rates in a hospital in the Southeastern United States. American Journal of Infection Control 44(12): 1729-1731, 2016

Sustained reduction in antimicrobial use and decrease in methicillin-resistant Staphylococcus aureus and Clostridium difficile infections following implementation of an electronic medical record at a tertiary-care teaching hospital. Journal of Antimicrobial ChemoTherapy 66(1): 205-209, 2011

The impact of hospital antimicrobial policy on the incidence of Clostridium difficile infection. International Journal of Pharmacy Practice 9(S1): 63-63, 2001

Severity and frequency of community-onset Clostridium difficile infection on an Australian tertiary referral hospital campus. International Journal of Infectious Diseases 29(): 152-155, 2016

Institutional review of the implementation and use of a Clostridium difficile infection bundle and probiotics in adult trauma patients. American Journal of Surgery: -, 2018

The fascination with probiotics for Clostridium difficile infection: lack of evidence for prophylactic or therapeutic efficacy. Anaerobe 15(6): 281-284, 2010

Discussion of "Institutional review of the implementation and use of a Clostridium difficile infection bundle and probiotics in adult trauma patients". American Journal of Surgery 215(5): 831-831, 2018

A bundle strategy including patient hand hygiene to decrease clostridium difficile infections. Medsurg Nursing 23(3): 145-8, 164, 2014

Defining acute renal dysfunction as a criterion for the severity of Clostridium difficile infection in patients with community-onset vs hospital-onset infection. Journal of Hospital Infection 83(4): 294-299, 2013

Incidence and Risk Factors for Community and Hospital Acquisition of Clostridium difficile Infection in the Tel Aviv Sourasky Medical Center. Infection Control and Hospital Epidemiology 38(8): 912-920, 2017

Impact of environmental decontamination using hydrogen peroxide vapour on the incidence of Clostridium difficile infection in one hospital Trust. Journal of Hospital Infection 78(3): 238-240, 2011

Healthcare-Associated Clostridium difficile Infections are Sustained by Disease from the Community. Bulletin of Mathematical Biology 79(10): 2242-2257, 2017

Frequent hospital readmissions for Clostridium difficile infection and the impact on estimates of hospital-associated C. difficile burden. Infection Control and Hospital Epidemiology 33(1): 20-28, 2012